We then evaluated the relationship between the CYTL1 protein levels and the survival rate in 80 breast cancer patients using IHC, 56 patients with lower CYTL1 expression showed a significantly poor overall survival as compared with 24 patients with higher CYTL1 level (Fig. 1c). The gene discussed is CYTL1; the disease is breast carcinoma.